Radiotherapy is a crucial cancer treatment and a career in this field offers a chance to impact people’s lives ...

GSK announced that belantamab mafodotin (Blenrep) plus bortezomib (Velcade) and dexamethasone improved overall survival in ...

The FDA granted accelerated approved to the first gene therapy directly administered into the brain on Nov. 14. The therapy, Kebilidi, was approved to treat adults and children with aromatic L-amino ...

Providence South Division Cancer Institute, serving the health organization’s 17 California hospitals, earned recognition for ...

It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, ...

GSA Capital Partners LLP lowered its holdings in Accuray Incorporated (NASDAQ:ARAY – Free Report) by 18.3% during the third ...

Los Angeles Capital Management LLC bought a new position in Accuray Incorporated (NASDAQ:ARAY – Free Report) in the third quarter, according to its most recent disclosure with the Securities and ...

Colorectal cancer is now the leading killer for those under 50. Two individuals have shared their experiences with Newsweek.

The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus ...

Brain tumours can be cancerous or non-cancerous, with varying growth rates and symptoms like headaches, vision changes, and ...

The Portneuf Cancer Center has further modernized its facility after acquiring a new state-of-the-art linear accelerator ...